SBFM insider filings
Sunshine Biopharma Inc. — 10 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-11. Screen SBFM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for SBFM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Sunshine Biopharma Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-11 | 4 | NATAN DAVID — Director | Grant/award (A): 58,300 @ $0 | EDGAR |
| 2026-04-14 | 4 | NATAN DAVID — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2024-03-05 | 4 | Slilaty Steve N. — Chief Executive Officer, Director, 10% owner | Purchase (P): 100,000 @ $0.10 | EDGAR |
| 2024-02-12 | 4 | Slilaty Steve N. — Chief Executive Officer, Director, 10% owner | Purchase (P): 20,000 @ $0.10 | EDGAR |
| 2022-12-02 | 4 | Sebaaly Camille — CFO/Secretary | Purchase (P): 30,000 @ $0.76 | EDGAR |
| 2022-06-06 | 4 | Sebaaly Camille — CFO/Secretary | Purchase (P): 25,000 @ $1.22 | EDGAR |
| 2022-02-22 | 4 | Slilaty Steve N. — Chief Executive Officer, Director | Disposition to issuer (D): 990,000 @ $0.10 | EDGAR |
| 2021-02-16 | 4 | MERZOUKI ABDERRAZZAK — Chief Operating Officer, Director | Grant/award (A): 20,000,000 @ $0.00 | EDGAR |
| 2021-02-16 | 4 | Slilaty Steve N. — Chief Executive Officer, Director | Grant/award (A): 20,000,000 @ $0.00 | EDGAR |
| 2021-02-16 | 4 | Sebaaly Camille — CFO/Secretary, Director | Grant/award (A): 20,000,000 @ $0.00 | EDGAR |
Recent 8-K events — Sunshine Biopharma Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-10-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-11 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-03 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Sunshine Biopharma Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-300133 (S-1) — latest: Initial registration (S-1), filed 2026-11-18
- SEC file 333-299274 (S-1) — latest: Final prospectus (424B4), filed 2026-10-09
- SEC file 333-298626 (S-1) — latest: Initial registration (S-1), filed 2026-08-28
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SBFM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs